The tryptophan–kynurenine pathway in immunomodulation and cancer metastasis
Cancer Medicine · 2023-09 · 12 (18) · 18691-18701
DOI: 10.1002/cam4.6484 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Medicine, online erschienen am 29.08.2023. Verfasst von Charlise Basson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, School of Medicine, University of Pretoria, Pretoria, South Africa. Hauptthemen laut MEDLINE: Kynurenine, Tryptophan, Neoplasms, Immunomodulation. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NRF of Prof Anguelov, Research Development program of Dr JC Serem, Research Development program of Dr YN Hlophe.
Abstract (Originalsprache)
Introduction
The activation of the kynurenine pathway in cancer progression and metastasis through immunomodulatory pathways has drawn attention to the potential for kynurenine pathway inhibition. The activation of the kynurenine pathway, which results in the production of kynurenine metabolites through the degradation of tryptophan, promotes the development of intrinsically malignant properties in cancer cells while facilitating tumour immune escape. In addition, kynurenine metabolites act as biologically active substances to promote cancer development and metastasis.
Methods
A literature review was conducted to investigate the role of the tryptophan‐kynurenine pathway in immunomodulation and cancer metastasis.
Results
Evidence suggests that several enzymes and metabolites implicated in the kynurenine pathway are overexpressed in various cancers. As such, the tryptophan pathway represents a promising target for cancer treatment. However, downstream signalling pathways, including aryl hydrocarbon receptor activation, have previously induced diverse biological effects in various malignancies, which resulted in either the promotion or the inhibition of metastasis.
Conclusion
As a result, a thorough investigation of the kynurenine pathway and its regulatory mechanisms is necessary in order to properly comprehend the effects of kynurenine pathway activation involved in cancer development and metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, School of Medicine, University of Pretoria, Pretoria, South Africa.
- Department of Anatomy, School of Medicine, University of Pretoria, Pretoria, South Africa.
ORCID-Profile: Charlise Basson, June Cheptoo Serem, Yvette Nkondo Hlophe, Priyesh Bipath
Förderung
- NRF of Prof Anguelov
- Research Development program of Dr JC Serem
- Research Development program of Dr YN Hlophe
- School of Medicine Research Committee
Zitieren
APA
Basson, C., Serem, J. C., Hlophe, Y. N., & Bipath, P. (2023). The tryptophan–kynurenine pathway in immunomodulation and cancer metastasis. Cancer Medicine, 12(18), 18691-18701. https://doi.org/10.1002/cam4.6484
Vancouver
Basson C, Serem JC, Hlophe YN, Bipath P. The tryptophan–kynurenine pathway in immunomodulation and cancer metastasis. Cancer Medicine. 2023;12(18):18691-18701. doi:10.1002/cam4.6484
BibTeX
@article{Basson2023,
author = {Basson, Charlise and Serem, June Cheptoo and Hlophe, Yvette Nkondo and Bipath, Priyesh},
title = {The tryptophan–kynurenine pathway in immunomodulation and cancer metastasis},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {18},
pages = {18691--18701},
doi = {10.1002/cam4.6484}
}
EUVIMED